A groundbreaking new clinical trial has pinpointed a twice-weekly intermittent fasting regimen, commonly called the “5:2 diet,” as the most effective and sustainable strategy among three popular diets for improving blood sugar control in people with type 2 diabetes and obesity. The findings, presented at the ENDO 2025 conference in San Francisco, not only illuminate a promising approach for diabetes management but also have significant implications for Thailand, where diabetes rates are rising and dietary trends are keenly watched by both the medical community and the public.
The prevalence of diabetes, particularly type 2, has become a major public health concern in Thailand. According to data from the International Diabetes Federation, as of 2023 more than 7 million Thais were living with this chronic disease, with the majority classified as overweight or obese—a key risk factor for diabetes onset and progression (IDF Diabetes Atlas). The Thai Ministry of Public Health has long touted dietary modification as central to diabetes care, but choosing the most practical and effective diet remains a challenge for many individuals and clinicians. Against this backdrop, the recent study reported by SciTechDaily provides vital new evidence.
In the trial conducted at The First Affiliated Hospital of Zhengzhou University in China, 90 adults recently diagnosed with type 2 diabetes and struggling with obesity were assigned to one of three diet groups: intermittent energy restriction (IER, or the 5:2 fasting method), time-restricted eating (TRE, restricting eating to a 10-hour daily window), and continuous energy restriction (CER, standard daily calorie reduction). Over 16 weeks, participants were closely monitored by nutritionists to ensure adherence and dietary consistency.
Impressively, all three diets produced weight loss and improved blood sugar control, as measured by reductions in HbA1c, the standard marker for long-term glucose management. However, the 5:2 intermittent fasting group demonstrated the most pronounced metabolic benefits, including greater reductions in fasting blood sugar, better insulin sensitivity as measured by the Matsuda index, and a significant drop in triglyceride levels. This group also boasted the highest adherence rate at 85%, slightly ahead of the CER group and notably outperforming the TRE group. The study allowed for direct comparison under supervised conditions, minimizing variables that often muddy the results in real-world settings.
“While all three approaches helped, the twice-weekly fasting method stands out for its balance of efficacy and practicality,” said the lead researcher, a chief physician at Zhengzhou University, citing that sticking to a regimen is critical for real-world success. With only two fasting days each week and normal eating on the others, the IER plan was deemed manageable for most participants, reducing dropout rates—a persistent barrier in weight and diabetes management programs worldwide.
Significantly, the study found no marked differences in the incidence of mild hypoglycemia or adverse effects between the groups, highlighting the safety of intermittent fasting when properly supervised. Experts note this is particularly relevant in the Thai context, where concerns about low blood sugar episodes often deter patients from making abrupt dietary changes. However, the researchers and Thai endocrinologists alike urge that such diets should be implemented under medical advice, given individual variation in diabetes medication and baseline health status.
Drilling down into the numbers, participants in the study averaged a BMI of 31.7 (well above the obesity threshold for Asian populations), were predominantly male, and had been living with diabetes for just over a year. The HbA1c reductions observed—with the 5:2 group leading at an average decrease greater than that of the TRE and CER groups—translate to meaningful reductions in the risk of diabetic complications such as neuropathy, nephropathy, and heart disease. These effects are particularly urgent in Thailand, where diabetic complications account for significant disability and loss of quality of life, as shown in Ministry of Public Health reports (MoPH Thailand 2023 statistics).
The research has immediate clinical and cultural resonance for health professionals and patients in Thailand. Traditional Thai diets, often based on frequent small meals and rice as a staple, have undergone dramatic change in recent decades. The proliferation of processed foods, sugary beverages, and sedentary lifestyles—especially in urban centers like Bangkok—has fueled the diabetes epidemic. Intermittent fasting, in either the 5:2 model or other forms, aligns with Buddhist fasting practices and Thai beliefs in periodic dietary restraint, potentially increasing its acceptability for Thai patients.
A senior Thai endocrinologist at a leading Bangkok hospital commented, “This study gives clinicians stronger evidence to recommend intermittent fasting for suitable patients, especially when combined with traditional Thai meals rich in vegetables and moderate carbohydrates.” However, the endocrinologist stressed the importance of personalized assessment, since those with advanced diabetes, multiple medications, or elderly patients may need closer monitoring.
The study’s strengths lie in its design—a randomized, controlled comparison over 16 weeks—and its focus on both biomedical outcomes and patient adherence rates. Adherence is a particularly important consideration in Thailand, where economic, familial, and work pressures often hinder long-term dietary change. With the COVID-19 pandemic increasing home cooking and meal delivery, integrating manageable fasting protocols could blend well with existing routines if adapted thoughtfully.
Still, there are caveats. The trial lasted four months and included only individuals with newly diagnosed diabetes and without significant complications. Whether the benefits persist long-term, or extend to Thais with longstanding disease, older adults, or those on complex medication regimens remains unclear. Moreover, while caloric intake was carefully controlled in the study, real-life dietary quality and food choices could alter the impact of fasting protocols.
Over the years, Thailand has grappled with how to reconcile modern nutrition science with local customs and economic realities. Mass campaigns to reduce sugar in beverages and promote healthier school lunches are steps in the right direction, but overweight rates in youth continue to climb (UNICEF Thailand, 2024 report), indicating the need for broader, more personalized solutions. Emerging research like the ENDO 2025 trial provides fresh options.
Globally, intermittent fasting has drawn scientific and media attention for its potential benefits in metabolism, heart health, and weight control (Harvard Health Publishing). Yet, until now, direct head-to-head comparisons with other strategies in diabetic populations have been relatively scarce. This latest evidence boosts the credibility of structured fasting not merely as a weight-loss trend, but as a legitimate therapeutic tool for diabetes management.
Looking ahead, leading Thai research institutes have signaled intent to further investigate intermittent fasting’s role in the Southeast Asian population. Questions remain about its impact on traditional dietary patterns, patient satisfaction, and metabolic markers over extended follow-up periods. As interest surges, healthcare providers are urged to ensure that patients receive culturally appropriate counseling and ongoing support, rather than simply importing Western dieting fads wholesale.
For Thais seeking to manage or prevent type 2 diabetes, practical steps include discussing fasting protocols with a healthcare provider, considering integration with traditional food preferences, and approaching dietary change as a gradual, sustainable journey rather than a quick fix. Community-level education and support groups, whether in local temples or online forums, can enhance success and minimize feelings of isolation during lifestyle changes.
In conclusion, as diabetes rates climb and the need for effective, realistic solutions grows ever more acute in Thailand, the latest research suggests that twice-weekly intermittent fasting offers both hope and a practical path forward. By coupling cutting-edge science with Thai cultural sensibilities, the fight against diabetes can become not just more effective, but more attuned to the everyday realities and values of Thai society.
For those considering any new dietary regimen—especially those on diabetes medication—consultation with a qualified medical professional remains essential. Small steps, such as trying a single fasting day under monitoring or substituting white rice with whole grains, can have outsized benefits when thoughtfully applied. In the end, the answer to Thailand’s diabetes challenge may lie not in extreme diets, but in tailored, evidence-based changes that respect both science and tradition.
Citations: